Overview
- ARMI said Kamen has recused himself from all board activities while an independent review examines his contacts with Jeffrey Epstein.
- FIRST confirmed Kamen is on leave as an outside law firm conducts an independent review of his ties to Epstein.
- Sequel Med Tech engaged an external law firm to assess the disclosures and said Kamen has recused from oversight of the special-committee review.
- Beta Technologies placed Kamen on indefinite leave with an investigation underway, and XPRIZE said he is no longer involved with the group.
- Justice Department emails document a 2013 visit to Epstein’s Caribbean island and years of exchanges; Kamen has not been accused of wrongdoing and describes the interactions as limited.